Editas Medicine, Inc. (EDIT)
3.55
+0.47
(+15.26%)
USD |
NASDAQ |
May 27, 16:00
3.64
+0.09
(+2.54%)
After-Hours: 17:38
Editas Medicine Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -12.87M |
| Regeneron Pharmaceuticals, Inc. | -802.20M |
| Puma Biotechnology, Inc. | -11.33M |
| Precision BioSciences, Inc. | 0.745M |
| Black Diamond Therapeutics, Inc. | -0.185M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.06M |
| Cash from Investing (Quarterly) | 0.064M |
| Free Cash Flow | -141.09M |
| Free Cash Flow Per Share (Quarterly) | -0.2365 |
| Free Cash Flow to Equity (Quarterly) | -18.42M |
| Free Cash Flow to Firm (Quarterly) | -22.08M |
| Free Cash Flow Yield | -43.01% |